Target Price | €4.75 |
Price | €2.48 |
Potential |
91.53%
register free of charge
|
Number of Estimates | 1 |
1 Analyst has issued a MediClin price target 2025.
The average MediClin target price is €4.75.
This is
91.53%
register free of charge
|
|
A rating was issued by 1 analysts: 1 Analysts recommend MediClin to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the MediClin stock has an average upside potential 2025 of
91.53%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million € | 730.07 | 730.00 |
3.60% | 0.01% | |
EBITDA Margin | 8.76% | 12.43% |
15.79% | 41.90% | |
Net Margin | -1.50% | 2.15% |
211.00% | 243.68% |
1 Analyst has issued a sales forecast MediClin 2024 . The average MediClin sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast MediClin 2024 . The average MediClin EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share € | -0.23 | 0.33 |
215.00% | 243.48% | |
P/E | 7.76 | |
EV/Sales | 0.66 |
Based on analysts' sales estimates for 2024, the MediClin stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.